We are pleased to announce our virus product pipeline for 2025.
- Products will be available to order as inventory is created.
- Inactivated virus stocks, viral genetic material and purified/concentrated virus stocks for each listed virus strain will be added to our catalog at a later date. In the meantime, we are happy to create these products for customers on-demand on an ad hoc basis.
- For on-demand orders, pre-orders, large volume orders or rush orders for any listed products, please contact us at info@advancedvirology.com.
Noroviruses:
- Human norovirus Genogroup GI genotypes - 2, 3, 4, 6, 7, 8
- Human norovirus Genogroup GII genotypes - 2, 3, 4, 6, 7, 8, 12, 16, 20
- Both virus stocks and quantified viral genomic material will be available.
Influenza viruses:
- Five Influenza virus strains recommended by the FDA for inclusion in the 2024-2025 seasonal vaccine.
- Strains recommended for the 2025-2026 seasonal Influenza vaccine will be added after selection by the FDA.
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).
Strains:
- A/Victoria/4897/2022 (H1N1)pdm09-like virus
- A/Thailand/8/2022 (H3N2)-like virus
- A/Wisconsin/67/2022 (H1N1)pdm09-like virus
- A/Massachusetts/18/2022 (H3N2)-like virus
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus
Human Parainfluenza viruses:
- Parainfluenza virus Type 1
- Parainfluenza virus Type 2
- Parainfluenza virus Type 3
- Parainfluenza virus Type 4
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).
Human Metapneumoviruses:
- HMPV Type A1
- HMPV Type A2a
- HMPV Type A2b
- HMPV Type B1
- HMPV Type B2
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).
Respiratory Syncytial virus:
- Challenge strain vaccine and antiviral testing - Memphis-37
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).
Coronaviruses:
- Human coronavirus strain OC43
- Human coronavirus strain 229E
- Human coronavirus strain NL63
- Human coronavirus strain HKU1
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).
Flaviviruses:
- Yellow Fever vaccine strain 17-D
- West Nile virus strain NY-99
- Zika virus strain MR766
- Zika virus strain PRVABC59
- Dengue virus Type 1
- Dengue virus Type 2
- Dengue virus Type 3
- Dengue virus Type 4
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).
Alphaviruses:
- Sindbis virus (SINV) strain TR339.
- Chikungunya virus (CHIKV) vaccine strain 181/25
- Reporter protein expressing variants (EGFP, Nano-Luciferase, mCherry and miRFP670nano3).
- Reporter proteins inserted after the capsid (TaV) or after nsP3 nonstructural protein.
Chimeric alphaviruses:
- Allow the study of BSL-3 and Select Agent alphaviruses in BSL-2, non Select Agent approved laboratories.
- Suitable for use in vaccine studies, diagnostic test development, antibody development and receptor studies.
- Non-structural proteins - from Sindbis virus (SINV) strain TR339
- Structural proteins - VEEV (Trinidad Donkey or ZPC738 strains), EEEV (FL93 or INH9813 K3E strains), CHIKV (La Reunion strain) or WEEV (McMillan strain).
- Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase, mCherry).